Buy Gemphire Therapeutics Stock | GEMP Stock Price & Latest News | Public.com
GEMP

Gemphire Therapeutics

$0.00 (0.00%)Today
    View Gemphire Therapeutics (GEMP) stock trends here

    About GEMP

    Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product und...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.07
    -0.14
    -0.21
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.19

    Actual EPS
    Q1 2021

    Stats

    Market Cap$88,01M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$29.71
    1 Year Low$3.86
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app